CLMT vs PODD · rev $4.19B vs P/E 34, rev $2.07B
Calumet Specialty Products Partners (CLMT) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Calumet Specialty Products Partners (CLMT) is a specialty chemicals company listed on NASDAQ.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported CLMT revenue for 2024-12-31 was $4.19B. Net income was -$222.0M. Revenue was up 0.2% from 2023-12-31 to 2024-12-31. CLMT currently screens at market cap $2.89B.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
CLMT currently screens at market cap $2.89B. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the CLMT and PODD stock pages for the full models.
Not investment advice.